Rhoen Klinikum AG (ETR:RHK) has received a consensus rating of “Sell” from the seven research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is €22.17 ($25.78).
RHK has been the topic of several recent analyst reports. Warburg Research set a €25.50 ($29.65) price target on shares of Rhoen Klinikum and gave the company a “neutral” rating in a research note on Friday, May 3rd. Kepler Capital Markets set a €19.00 ($22.09) price target on shares of Rhoen Klinikum and gave the company a “sell” rating in a research note on Thursday, April 11th. Independent Research set a €152.00 ($176.74) price target on shares of Continental and gave the company a “neutral” rating in a research note on Friday, May 10th. Credit Suisse Group set a $100.00 price target on shares of Procter & Gamble and gave the company a “hold” rating in a research note on Friday, May 10th. Finally, Berenberg Bank restated a “sell” rating and set a GBX 600 ($7.84) target price on shares of Great Portland Estates in a research report on Friday, May 3rd.
Rhoen Klinikum stock traded down €0.05 ($0.06) during mid-day trading on Thursday, hitting €25.60 ($29.77). The company had a trading volume of 8,417 shares, compared to its average volume of 43,281. The stock has a market cap of $1.71 billion and a PE ratio of 36.57. Rhoen Klinikum has a 1 year low of €21.06 ($24.49) and a 1 year high of €27.40 ($31.86). The company has a debt-to-equity ratio of 9.74, a quick ratio of 1.61 and a current ratio of 1.76. The business has a fifty day moving average of €26.00.
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.
Further Reading: What is an Initial Public Offering (IPO)?
Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.